Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Livanova Plc OR Sh (LIVN)

Livanova Plc OR Sh (LIVN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,216,358
  • Shares Outstanding, K 48,445
  • Annual Sales, $ 1,084 M
  • Annual Income, $ -155,180 K
  • 60-Month Beta 0.37
  • Price/Sales 1.95
  • Price/Cash Flow 7.57
  • Price/Book 1.52

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/20
See More
  • Average Estimate 0.34
  • Number of Estimates 3
  • High Estimate 0.59
  • Low Estimate -0.14
  • Prior Year 0.43
  • Growth Rate Est. (year over year) -20.93%

Price Performance

See More
Period Period Low Period High Performance
1-Month
33.40 +35.48%
on 03/23/20
77.29 -41.45%
on 03/05/20
-24.47 (-35.10%)
since 02/28/20
3-Month
33.40 +35.48%
on 03/23/20
80.75 -43.96%
on 01/07/20
-30.15 (-39.99%)
since 12/27/19
52-Week
33.40 +35.48%
on 03/23/20
98.97 -54.28%
on 04/01/19
-52.00 (-53.47%)
since 03/29/19

Most Recent Stories

More News
LivaNova to Host Conference Call for First Quarter 2020 Results

LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, will host a conference call to discuss its first quarter 2020 results on Wednesday, April 29, 2020 at 1 p.m. London...

LIVN : 45.25 (-1.09%)
ShiraTronics, Inc. Completes $3 Million Additional Series A Financing

ShiraTronics, Inc., a private medical device company, today announced it has completed an additional Series A financing of $3 million bringing the Series A financing to a total of $36 million. The financing...

LIVN : 45.25 (-1.09%)
LivaNova Autonomic Regulation Therapy for Heart Failure Findings to be Presented at American College of Cardiology and World Congress of Cardiology Virtual Meeting

LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced two abstracts focused on implantable neuromodulation technology for patients with heart failure will...

LIVN : 45.25 (-1.09%)
Neuromodulation Devices Market to Hit USD 9.34 Billion by 2026; Increasing Patient Population Worldwide to Feed Market Expansion: Fortune Business Insights(TM)

The global neuromodulation devices market size is projected to reach USD 9.34 billion by 2026, exhibiting a CAGR of 9.5% during the forecast period. Steady climb in the prevalence of chronic conditions...

BSX : 32.63 (+3.13%)
LIVN : 45.25 (-1.09%)
MDT : 90.18 (-2.03%)
Cardiovascular Devices Market to Rise at 6.4% CAGR; Increasing Prevalence of Heart Diseases Will Boost Market, projects Fortune Business Insights(TM)

The global cardiovascular devices market size is prognosticated to reach USD 82.20 billion by 2026 on account of the increasing cases of cardiovascular diseases such as coronary artery disease, heart failure,...

BSX : 32.63 (+3.13%)
CSII : 35.21 (-0.87%)
EW : 188.62 (-3.79%)
GE : 7.94 (+0.63%)
JNJ : 131.13 (-1.41%)
LIVN : 45.25 (-1.09%)
SIEGY : 42.0000 (+0.94%)
Global Valvular Heart Disease Treatment Market 2019 Industry Outlook, Comprehensive Insights, Growth and Forecast 2025

, a new addition to the catalog of Fior Markets, provides an overview of the current state of the market and its evolution. The report contains a forecast of 2019 and ending 2025 with key aspects such...

BSX : 32.63 (+3.13%)
CRY : 16.92 (+2.92%)
EW : 188.62 (-3.79%)
LIVN : 45.25 (-1.09%)
MDT : 90.18 (-2.03%)
NVCN.TO : 2.08 (-5.88%)
LivaNova VNS Therapy System, Symmetry, Granted CE Mark for Difficult-to-Treat Depression

LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced its Vagus Nerve Stimulation Therapy(R) (VNS Therapy) System, Symmetry(TM), earned CE Mark approval...

LIVN : 45.25 (-1.09%)
Vagus Nerve Stimulation Market to Hit $1,194.4 Mn by 2026; Rising Demand for VNS Method for Treating Chronic Disorders to Favor Market Growth: Fortune Business Insights(TM)

Vagus Nerve Stimulation (VNS) Market Overview

LIVN : 45.25 (-1.09%)
LivaNova Enters Research Collaboration with Verily to Gain New Insights into Vagus Nerve Stimulation Impact on Difficult-to-Treat Depression

LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced a research collaboration with Verily, an Alphabet company, to capture measures of depression within...

LIVN : 45.25 (-1.09%)
LivaNova (LIVN) Q4 Earnings Top Estimates

LivaNova (LIVN) delivered earnings and revenue surprises of 5.26% and -1.54%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?

LIVN : 45.25 (-1.09%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade LIVN with:

Business Summary

LivaNova PLC is a medical technology company which focuses on providing treatment for cardiovascular diseases and neuromodulation. The Company's operating units consists of Cardiac Rhythm Management, Cardiac Surgery and Neuromodulation. LivaNova PLC, formerly known as Cyberonics, Inc., is based in London,...

See More

Key Turning Points

2nd Resistance Point 47.99
1st Resistance Point 46.62
Last Price 45.25
1st Support Level 44.30
2nd Support Level 43.35

See More

52-Week High 98.97
Fibonacci 61.8% 73.92
Fibonacci 50% 66.18
Fibonacci 38.2% 58.45
Last Price 45.25
52-Week Low 33.40

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar